| Literature DB >> 28719283 |
Alex Gendernalik1, James Weger-Lucarelli1, Selene M Garcia Luna1, Joseph R Fauver1, Claudia Rückert1, Reyes A Murrieta1, Nicholas Bergren1, Demitrios Samaras1, Chilinh Nguyen1, Rebekah C Kading1, Gregory D Ebel1.
Abstract
AbstractStarting in 2013-2014, the Americas have experienced a massive outbreak of Zika virus (ZIKV) which has now reached at least 49 countries. Although most cases have occurred in South America and the Caribbean, imported and autochthonous cases have occurred in the United States. Aedes aegypti and Aedes albopictus mosquitoes are known vectors of ZIKV. Little is known about the potential for temperate Aedes mosquitoes to transmit ZIKV. Aedes vexans has a worldwide distribution, is highly abundant in particular localities, aggressively bites humans, and is a competent vector of several arboviruses. However, it is not clear whether Ae. vexans mosquitoes are competent to transmit ZIKV. To determine the vector competence of Ae. vexans for ZIKV, wild-caught mosquitoes were exposed to an infectious bloodmeal containing a ZIKV strain isolated during the current outbreak. Approximately 80% of 148 mosquitoes tested became infected by ZIKV, and approximately 5% transmitted infectious virus after 14 days of extrinsic incubation. These results establish that Ae. vexans are competent ZIKV vectors. Their relative importance as vectors (i.e., their vectorial capacity) depends on feeding behavior, longevity, and other factors that are likely to vary in ecologically distinct environments.Entities:
Mesh:
Year: 2017 PMID: 28719283 PMCID: PMC5462567 DOI: 10.4269/ajtmh.16-0963
Source DB: PubMed Journal: Am J Trop Med Hyg ISSN: 0002-9637 Impact factor: 2.345
Competence of Aedes vexans mosquitoes as vectors of Zika virus, number of virus positive/number bloodfed (%; 95% CI)
| Experiment | Infected | Disseminated | Transmitted | Bloodmeal titer | |
|---|---|---|---|---|---|
| Genomes/mL | PFU/mL | ||||
| BR1 | 38/58 (66) | 2/58 (3) | 1/58 (2) | 4.15E + 10 | 7.00E + 06 |
| BR2 | 53/58 (91) | 14/58 (24) | 4/58 (7) | 3.05E + 10 | 1.30E + 07 |
| BR3 | 27/32 (84) | 8/32 (25) | 2/32 (6) | 2.76E + 10 | 1.70E + 07 |
| Total | 118/148 (80; 48.3 to 112.37) | 24/148 (16; −13.53 to 48.19) | 7/148 (5; −1.57 to 11.57) | ||
CI = confidence interval; PFU = plaque-forming units.